NCT07509021 Neuropathic Pain, Catastrophizing, and Adherence in SAIS
| NCT ID | NCT07509021 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Abant Izzet Baysal University |
| Condition | Subacromial Impingement Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2026-04-02 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2026-04-02 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Subacromial impingement syndrome is one of the most common causes of shoulder pain and may negatively affect daily activities and quality of life. While shoulder pain is usually considered nociceptive, some patients may also have a neuropathic pain component, which can influence symptom severity and treatment outcomes. In addition, psychological factors such as pain catastrophizing and adherence-related behavior may play an important role in recovery. This prospective observational study aims to evaluate the presence of neuropathic pain in patients with subacromial impingement syndrome and to investigate its relationship with pain catastrophizing and adherence-related behavior. Patients undergoing a standard physical therapy program will be assessed at the beginning and after completion of treatment using validated clinical scales. The findings of this study may help to better understand the interaction between pain characteristics, psychological factors, and adherence-related behavior, and contribute to the development of more individualized rehabilitation strategies
Eligibility Criteria
Inclusion Criteria: * Unilateral subacromial impingement syndrome lasting at least 3 months * Planned to start a 10-session physical therapy program * Willing and able to provide informed consent Exclusion Criteria: * Upper extremity entrapment neuropathy or polyneuropathy * History of diabetes mellitus * Inflammatory rheumatic disease, infection, or malignancy * Frozen shoulder * History of shoulder fracture, dislocation, or surgery * Complete rotator cuff tear on magnetic resonance imaging * Calcific tendinitis * Shoulder steroid injection or physical therapy within the previous 3 months * Use of medication for neuropathic pain * Pregnancy * Cognitive impairment preventing completion of questionnaires
Contact & Investigator
Yakup ERDEN, MD
PRINCIPAL INVESTIGATOR
Clinic of Physical Medicine and Rehabilitation, İzzet Baysal Physical Treatment and Rehabilitation Training and Research Hospital
Frequently Asked Questions
Who can join the NCT07509021 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Subacromial Impingement Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07509021 currently recruiting?
Yes, NCT07509021 is actively recruiting participants. Contact the research team at yakuperden@hotmail.com for enrollment information.
Where is the NCT07509021 trial being conducted?
This trial is being conducted at Bolu, Turkey (Türkiye).
Who is sponsoring the NCT07509021 clinical trial?
NCT07509021 is sponsored by Abant Izzet Baysal University. The principal investigator is Yakup ERDEN, MD at Clinic of Physical Medicine and Rehabilitation, İzzet Baysal Physical Treatment and Rehabilitation Training and Research Hospital. The trial plans to enroll 75 participants.